PTPN1 and type 2 diabetes mellitus: According to Han et al. (2020), the protein tyrosine phosphatase 1B (PTP1B) enzyme was a confirmed biological target for treating Type II diabetes mellitus for its negative regulatory effect towards insulin signaling cascade.